Skip to main content
. 2016 Aug 28;22(32):7264–7274. doi: 10.3748/wjg.v22.i32.7264

Figure 1.

Figure 1

Prevalence of hepatitis B surface antigen in some provinces in Indonesia[11]. The provided number is the average number across all age groups, including the individuals born before and after the introduction of the immunization program. The population were those with more than 1 year of age (general population) in 2007, after 10 years of implementation of national hepatitis B immunization. For the provinces without the prevalence number, there are no available data (https://commons.wikimedia.org/wiki/File:Indonesia,_administrative_divisions_-_en_-_monochrome.sv).